Annual Report - Investor Centre | AFT Pharmaceuticals

40

Transcript of Annual Report - Investor Centre | AFT Pharmaceuticals

Page 1: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 2: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 3: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 4: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 5: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 6: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 7: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 8: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 9: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 10: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 11: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 12: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 13: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 14: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 15: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 16: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 17: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 18: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 19: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 20: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 21: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 22: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 23: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 24: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 25: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 26: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 27: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 28: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 29: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 30: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 31: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 32: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 33: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 34: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 35: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 36: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 37: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 38: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 39: Annual Report - Investor Centre | AFT Pharmaceuticals
Page 40: Annual Report - Investor Centre | AFT Pharmaceuticals

Torrent Pharmaceuticals Ltd Investor Presentation Q1 FY 2012.

Torrent Pharmaceuticals Ltd Investor Presentation Q1 FY 2012.

Addex Pharmaceuticals Investor Presentation July 2010

Addex Pharmaceuticals Investor Presentation July 2010

AFT PHARMACEUTICALS - ASX · June 2016. 5. ACCELERATING CLINICAL STUDY PROGRAM • 12 studies across the AFT portfolio • 1500+ patients • 7 countries - Australia, Jordan, Mexico,

AFT PHARMACEUTICALS - ASX · June 2016. 5. ACCELERATING CLINICAL STUDY PROGRAM • 12 studies across the AFT portfolio • 1500+ patients • 7 countries - Australia, Jordan, Mexico,

IOL Chemicals and Pharmaceuticals Limited Investor ... Presentation - IOL_16...2021/02/16  · About IOL Chemicals and Pharmaceuticals Limited Incorporated in 1986, IOLCP is one of

IOL Chemicals and Pharmaceuticals Limited Investor ... Presentation - IOL_16...2021/02/16  · About IOL Chemicals and Pharmaceuticals Limited Incorporated in 1986, IOLCP is one of

NPS Pharmaceuticals Investor Slide Deck

NPS Pharmaceuticals Investor Slide Deck

TRACON PHARMACEUTICALS Investor Presentation

TRACON PHARMACEUTICALS Investor Presentation

Symposium Investor Roadshow November 2015 - MGC Pharmaceuticals

Symposium Investor Roadshow November 2015 - MGC Pharmaceuticals

Inovio Pharmaceuticals 2012 Investor Presentation

Inovio Pharmaceuticals 2012 Investor Presentation

Addex Pharmaceuticals Investor Relations Presentation October 2009.

Addex Pharmaceuticals Investor Relations Presentation October 2009.

Addex Pharmaceuticals Investor Presentation February 2010.

Addex Pharmaceuticals Investor Presentation February 2010.

Valeant Pharmaceuticals - Pershing Square …assets.pershingsquareholdings.com/2014/09/Investor-Call...Valeant Pharmaceuticals International (VRX) Multinational specialty pharmaceutical

Valeant Pharmaceuticals - Pershing Square …assets.pershingsquareholdings.com/2014/09/Investor-Call...Valeant Pharmaceuticals International (VRX) Multinational specialty pharmaceutical

Australian Public Assessment Report for Diltiazem … · Web viewAustralian Public Assessment Report for Diltiazem hydrochloride Proprietary Product Name: Ano-Cream Sponsor: AFT Pharmaceuticals

Australian Public Assessment Report for Diltiazem … · Web viewAustralian Public Assessment Report for Diltiazem hydrochloride Proprietary Product Name: Ano-Cream Sponsor: AFT Pharmaceuticals

AFT PHARMACEUTICALS - Bioshares...Queenstown, New Zealand Bioshares Presentation July 2018 IMPORTANT NOTICE This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”),

AFT PHARMACEUTICALS - Bioshares...Queenstown, New Zealand Bioshares Presentation July 2018 IMPORTANT NOTICE This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”),

Valeant Pharmaceuticals International, Inc./media/Files/V/Valeant-IR/... · 2015-12-09 · Valeant Pharmaceuticals International, Inc. Investor Conference Call October 26, 2015 .

Valeant Pharmaceuticals International, Inc./media/Files/V/Valeant-IR/... · 2015-12-09 · Valeant Pharmaceuticals International, Inc. Investor Conference Call October 26, 2015 .

Addex Pharmaceuticals Investor Presentation July 2010.

Addex Pharmaceuticals Investor Presentation July 2010.

INVESTOR PRESENTATION MAY 2019INVESTOR PRESENTATION MAY 2019 Important Notice 2 This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general

INVESTOR PRESENTATION MAY 2019INVESTOR PRESENTATION MAY 2019 Important Notice 2 This presentation has been prepared by AFT Pharmaceuticals Limited (“AFT”), to provide a general

ACTELION’S CARDIOVASCULAR PIPELINE INVESTOR WEBCAST · © 2016 Actelion Pharmaceuticals Ltd PULMONARY AND SYSTEMIC CIRCULATION PATHWAYS 4 07 Nov 2016 Investor webcast

ACTELION’S CARDIOVASCULAR PIPELINE INVESTOR WEBCAST · © 2016 Actelion Pharmaceuticals Ltd PULMONARY AND SYSTEMIC CIRCULATION PATHWAYS 4 07 Nov 2016 Investor webcast

FINANCIAL REPORT 2008 - TAJ PHARMACEUTICALS GROUP...Taj Pharmaceuticals Limited (the "Company") believes that the information included in the Investor Relations section of this website

FINANCIAL REPORT 2008 - TAJ PHARMACEUTICALS GROUP...Taj Pharmaceuticals Limited (the "Company") believes that the information included in the Investor Relations section of this website

BAFNA PHARMACEUTICALS LIMITEDbafnapharma.com/pdf/NOTICE-OF-21st-AGM.pdf · BAFNA PHARMACEUTICALS LIMITED CIN ... the shareholders may also send requests to the Company‟s investor

BAFNA PHARMACEUTICALS LIMITEDbafnapharma.com/pdf/NOTICE-OF-21st-AGM.pdf · BAFNA PHARMACEUTICALS LIMITED CIN ... the shareholders may also send requests to the Company‟s investor

Valeant Pharmaceuticals International (VRX) Earnings ... · The following Valeant Pharmaceuticals International conference call took place ... , everyone. Welcome to Valeant's investor

Valeant Pharmaceuticals International (VRX) Earnings ... · The following Valeant Pharmaceuticals International conference call took place ... , everyone. Welcome to Valeant's investor